BERRINO, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 2.319
AS - Asia 1.520
EU - Europa 1.226
SA - Sud America 201
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 17
Totale 5.387
Nazione #
US - Stati Uniti d'America 2.281
RU - Federazione Russa 557
CN - Cina 496
SG - Singapore 377
IT - Italia 330
KR - Corea 163
BR - Brasile 155
VN - Vietnam 151
HK - Hong Kong 135
IE - Irlanda 73
IN - India 51
PL - Polonia 51
SE - Svezia 51
FR - Francia 44
FI - Finlandia 37
BD - Bangladesh 33
DE - Germania 30
ID - Indonesia 22
CA - Canada 18
GB - Regno Unito 18
AU - Australia 17
AR - Argentina 16
IQ - Iraq 14
TR - Turchia 14
NG - Nigeria 13
JP - Giappone 12
MA - Marocco 11
MX - Messico 11
JO - Giordania 10
NL - Olanda 9
PH - Filippine 8
CO - Colombia 7
EG - Egitto 7
BJ - Benin 6
EC - Ecuador 6
PK - Pakistan 6
SA - Arabia Saudita 6
ZA - Sudafrica 6
PY - Paraguay 5
TW - Taiwan 5
UA - Ucraina 5
VE - Venezuela 5
CL - Cile 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
IR - Iran 3
KE - Kenya 3
LT - Lituania 3
BB - Barbados 2
BE - Belgio 2
DK - Danimarca 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
NO - Norvegia 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.338
Città #
Santa Clara 805
Singapore 307
Ashburn 294
Hefei 196
Seoul 161
San Jose 157
Hong Kong 110
Fairfield 76
Dublin 70
Moscow 66
Council Bluffs 64
Beijing 63
Warsaw 50
Ho Chi Minh City 46
Rome 40
Seattle 40
Chandler 38
Woodbridge 37
Milan 36
Houston 33
Hanoi 32
Altamura 28
Buffalo 28
Lauterbourg 28
Lawrence 28
Cambridge 27
Mumbai 27
Wilmington 27
Dallas 26
Helsinki 25
Los Angeles 24
Florence 23
Ann Arbor 19
Kent 18
Phoenix 18
Melbourne 17
Princeton 16
São Paulo 16
The Dalles 16
Boardman 15
Chicago 14
Jakarta 14
Medford 14
Abuja 13
New York 13
Shanghai 13
Naples 12
Bengaluru 10
Tokyo 10
Biên Hòa 9
Munich 8
San Diego 8
Boston 7
Brasília 7
Paris 7
Cagliari 6
Cotonou 6
Dong Ket 6
Dummerstorf 6
Lappeenranta 6
Messina 6
Mexico City 6
Orem 6
Padua 6
San Francisco 6
Turku 6
West Jordan 6
Atlanta 5
Casablanca 5
Clifton 5
Falkenstein 5
Frankfurt am Main 5
Genoa 5
Haiphong 5
Venice 5
Washington 5
Amman 4
Baghdad 4
Belo Horizonte 4
Bologna 4
Calgary 4
Catania 4
Charlotte 4
Curitiba 4
Goiânia 4
Guangzhou 4
Guayaquil 4
London 4
Najaf 4
Newark 4
Norwalk 4
Taipei 4
Toronto 4
Turin 4
Yubileyny 4
Abidjan 3
Bari 3
Can Tho 3
Cascina 3
Chennai 3
Totale 3.514
Nome #
Carbonic Anhydrase Inhibitors: Versatile Agents for the Treatment of Human Diseases 316
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 211
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 199
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors 194
1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity 191
Escinosome thermosensitive gel optimizes efficacy of CAI-CORM in a rat model of rheumatoid arthritis 186
Azidothymidine "clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors 177
Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates 172
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 165
Carbonic anhydrase inhibitors of different structures dilate pre-contracted porcine retinal arteries 161
A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors 151
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration 148
Dual carbonic anhydrase ix/xii inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages 144
SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX 140
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 138
An innovative spectroscopic approach for qualitative and quantitative evaluation of Mb-CO from myoglobin carbonylation reaction through chemometrics methods 137
Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies 136
Carbonic anhydrase inhibitors for the treatment of epilepsy and obesity 135
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 134
N-aryl-N′-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions 133
Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer 132
New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies 128
Rho-kinase inhibitors in the management of glaucoma 127
Novel approaches for designing drugs that interfere with pH regulation 126
Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms with N'-aryl-N-hydroxy-ureas 124
Modulating the Efficacy of Carbonic Anhydrase Inhibitors through Fluorine Substitution 122
Superacid-Synthesized Fluorinated Diamines Act as Selective hCA IV Inhibitors 119
Carbon Monoxide Release from Aryl-Propargyl Dicobalt(0)Hexacarbonyl Derivatives: A Computational and Experimental Study 119
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 119
Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as carbonic anhydrase inhibitors: synthesis, characterisation and biological evaluation 117
New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases 113
In Vitro CO-Releasing and Antioxidant Properties of Sulfonamide-Based CAI-CORMs in a H2O2-Stimulated Human Achilles Tendon-Derived Cell Model 112
Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases 112
Novel Insights on Human Carbonic Anhydrase Inhibitors Based on Coumalic Acid: Design, Synthesis, Molecular Modeling Investigation, and Biological Studies 104
Zeta-carbonic anhydrases show CS2 hydrolase activity: A new metabolic carbon acquisition pathway in diatoms? 103
Advances in microwave-assisted synthesis and the impact of novel drug discovery 97
Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes 95
Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid 50
Totale 5.387
Categoria #
all - tutte 16.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 0 0 0 8 5 19 1 6 9 8 9 32
2022/2023294 30 73 29 3 10 41 21 10 25 21 23 8
2023/2024293 7 19 39 18 30 34 9 73 12 35 7 10
2024/20251.813 42 178 91 224 609 325 34 36 71 28 71 104
2025/20262.226 218 358 339 227 195 62 198 106 153 121 79 170
2026/2027268 64 63 138 3 0 0 0 0 0 0 0 0
Totale 5.387